Investors Purchase Large Volume of Call Options on CVS Health (NYSE:CVS)

CVS Health Corporation (NYSE:CVS) was the recipient of some unusual options trading on Wednesday. Stock investors purchased 23,271 call options on the stock. This is an increase of 33% compared to the average volume of 17,551 call options.

CVS Health Stock Up 1.6%

Shares of NYSE CVS traded up $1.36 during trading hours on Wednesday, hitting $87.79. 6,876,946 shares of the stock were exchanged, compared to its average volume of 8,291,995. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.74. The company has a market cap of $112.28 billion, a PE ratio of 23.22, a PEG ratio of 0.85 and a beta of 0.60. CVS Health has a 12 month low of $69.51 and a 12 month high of $110.68. The firm has a fifty day moving average price of $93.81 and a 200-day moving average price of $92.19.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 EPS for the quarter, beating the consensus estimate of $1.87 by $0.71. The company had revenue of $106.10 billion for the quarter, compared to analyst estimates of $100.03 billion. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The firm’s revenue was up 7.3% on a year-over-year basis. During the same period in the prior year, the company earned $1.81 earnings per share. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. On average, sell-side analysts expect that CVS Health will post 8.02 EPS for the current year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, November 2nd. Stockholders of record on Thursday, October 22nd will be given a dividend of $0.6650 per share. This represents a $2.66 annualized dividend and a dividend yield of 3.0%. The ex-dividend date of this dividend is Thursday, October 22nd. CVS Health’s dividend payout ratio is currently 70.37%.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on CVS. JPMorgan Chase & Co. upped their price target on CVS Health from $111.00 to $118.00 and gave the company an “overweight” rating in a research report on Wednesday, August 12th. Robert W. Baird set a $107.00 target price on CVS Health in a research report on Thursday, August 6th. Royal Bank Of Canada lifted their price objective on shares of CVS Health from $107.00 to $113.00 and gave the stock an “outperform” rating in a report on Thursday, July 9th. Truist Financial lifted their price target on shares of CVS Health from $108.00 to $118.00 and gave the stock a “buy” rating in a research note on Tuesday, July 14th. Finally, UBS Group reaffirmed a “buy” rating on shares of CVS Health in a research note on Tuesday, September 22nd. Twenty-two investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, CVS Health currently has an average rating of “Moderate Buy” and an average target price of $107.24.

CVS Health News Summary

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: Health Care Benefits outlook improves: CVS raised its outlook for the segment as stronger underlying trends, particularly in Medicare, are expected to support margin recovery despite continued medical-cost pressure. This is the most significant fundamental catalyst in the recent coverage. CVS’ Health Care Benefits Arm Shows Better Core Trends: What’s Ahead?
• Positive Sentiment: Valuation seen as attractive: Commentary from Jim Cramer characterized CVS as “insanely cheap,” suggesting that much of the company’s negative news may already be reflected in its valuation. This could encourage bargain-focused investors. Why CVS Is ‘Insanely Cheap,’ ON Semi a Laggard Catching Up, and Grail Too Expensive to Chase
• Positive Sentiment: Pharmacy access expansion: CVS opened its first pharmacy-focused location in the Boston area, providing medications, immunizations and pharmacist-led care in Roxbury. The initiative may strengthen community access and support pharmacy-service growth, although the near-term financial impact is likely limited. CVS Pharmacy celebrates opening of first pharmacy-focused location in Boston area
• Positive Sentiment: Vaccination demand opportunity: CVS reminded New York residents that MMR vaccines are available at more than 530 pharmacies and MinuteClinic locations amid a measles outbreak. The announcement reinforces CVS’s role in preventive care and could modestly increase pharmacy and clinic activity. CVS Health reminds New Yorkers that MMR vaccines are available statewide amid measles outbreak
• Neutral Sentiment: Analyst target remains above the market: Coverage cites a consensus price target of $107.24, indicating potential upside based on analyst expectations, though the target itself is not a new earnings or business announcement. CVS Health Corporation Stock Has Consensus Price Target of $107.24 According to Analysts
• Negative Sentiment: Dividend appeal trails UnitedHealth: A comparison for retirees highlights that CVS pays a substantially smaller annual dividend than UnitedHealth. This may limit enthusiasm among income-focused investors, even though CVS’s valuation and operating outlook appear more supportive. Better Dividend Stock for Retirees: CVS vs. UnitedHealth

Institutional Investors Weigh In On CVS Health

Institutional investors have recently added to or reduced their stakes in the business. Rosenberg Matthew Hamilton grew its holdings in CVS Health by 97.4% in the third quarter. Rosenberg Matthew Hamilton now owns 1,775 shares of the pharmacy operator’s stock valued at $152,000 after purchasing an additional 876 shares during the period. CapWealth Advisors LLC lifted its stake in shares of CVS Health by 1.4% during the third quarter. CapWealth Advisors LLC now owns 344,416 shares of the pharmacy operator’s stock worth $29,513,000 after purchasing an additional 4,814 shares in the last quarter. Argent Capital Management LLC raised its stake in shares of CVS Health by 50.4% during the third quarter. Argent Capital Management LLC now owns 238,110 shares of the pharmacy operator’s stock valued at $20,404,000 after purchasing an additional 79,822 shares during the period. MassMutual Private Wealth & Trust FSB grew its holdings in CVS Health by 21.0% during the 3rd quarter. MassMutual Private Wealth & Trust FSB now owns 5,003 shares of the pharmacy operator’s stock valued at $429,000 after purchasing an additional 868 shares in the last quarter. Finally, Boltwood Capital Management boosted its position in CVS Health by 5.0% in the 3rd quarter. Boltwood Capital Management now owns 9,877 shares of the pharmacy operator’s stock valued at $846,000 after buying an additional 470 shares during the last quarter. Hedge funds and other institutional investors own 80.66% of the company’s stock.

CVS Health Company Profile

CVS Health Corp. is an integrated health care company that provides pharmacy, insurance and health services primarily in the United States. Its operations are designed to connect consumers, health plans, health care providers and pharmacy services across multiple points of care.

The company’s major businesses include CVS Pharmacy retail locations, prescription fulfillment and consumer health products; CVS Caremark, a pharmacy benefit management business; and Aetna, which offers health insurance products and related services for employers, individuals, government programs and other organizations.